skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system

Journal Article · · PLoS ONE

Research Organization:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institutes of Health (NIH)
Grant/Contract Number:
AC52-07NA27344
OSTI ID:
1361453
Alternate ID(s):
OSTI ID: 1395310; OSTI ID: 1515333
Report Number(s):
LLNL-JRNL-737725; 10.1371/journal.pone.0177761
Journal Information:
PLoS ONE, Journal Name: PLoS ONE Vol. 12 Journal Issue: 6; ISSN 1932-6203
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 4 works
Citation information provided by
Web of Science

References (59)

Update on HER1–3 in Advanced Non–Small-Cell Lung Cancer journal December 2012
Advances in the use of nanoscale bilayers to study membrane protein structure and function journal January 2014
The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions journal June 1997
Comparing the Epidermal Growth Factor Interaction with Four Different Cell Lines: Intriguing Effects Imply Strong Dependency of Cellular Context journal January 2011
Isolation, Characterization, and Stability of Discretely-Sized Nanolipoprotein Particles Assembled with Apolipophorin-III journal July 2010
Epidermal growth factor receptor mutations in lung cancer journal March 2007
Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors journal August 2009
The deaf and the dumb: the biology of ErbB-2 and ErbB-3 journal March 2003
EGFR Signaling and Drug Discovery journal January 2009
Molecular pathology of lung cancer: key to personalized medicine journal January 2012
Nanodiscs as a New Tool to Examine Lipid–Protein Interactions book December 2012
Different Apolipoproteins Impact Nanolipoprotein Particle Formation
  • Chromy, Brett A.; Arroyo, Erin; Blanchette, Craig D.
  • Journal of the American Chemical Society, Vol. 129, Issue 46, p. 14348-14354 https://doi.org/10.1021/ja074753y
journal November 2007
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib journal February 2005
An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors journal September 2003
The Membrane Mimetic Affects the Spatial Structure and Mobility of EGFR Transmembrane and Juxtamembrane Domains journal October 2015
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer journal May 1989
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain journal February 2005
Hydrogen Production by a Hyperthermophilic Membrane-Bound Hydrogenase in Water-Soluble Nanolipoprotein Particles journal June 2009
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3 journal January 2007
Epidermal Growth Factor Receptor (EGFR) Antibody Down-regulates Mutant Receptors and Inhibits Tumors Expressing EGFR Mutations journal November 2006
Applications of Phospholipid Bilayer Nanodiscs in the Study of Membranes and Membrane Proteins journal February 2007
Expression of the human EGF receptor with ligand-stimulatable kinase activity in insect cells using a baculovirus vector. journal January 1988
A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling journal July 1994
Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment journal June 2009
Autophosphorylation activation and inhibition by curcumin of the epidermal growth factor receptor reconstituted in liposomes: AUTOPHOSPHORYLATION AND INHIBITION OF EGFR IN LIPOSOMES journal October 2012
Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors journal November 2006
A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment journal November 2011
Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation journal December 2010
Characterization and Purification of Polydisperse Reconstituted Lipoproteins and Nanolipoprotein Particles journal July 2009
The Biology of Epidermal Growth Factor Receptor in Lung Cancer journal June 2004
Mechanisms of tumor resistance to EGFR-targeted therapies journal March 2009
The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain journal June 2009
Specificity within the EGF family/ErbB receptor family signaling network journal January 1998
Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas journal August 2014
Epidermal Growth Factor Receptor Dimerization and Activation Require Ligand-Induced Conformational Changes in the Dimer Interface journal August 2005
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer journal May 2008
The Juxtamembrane Region of EGFR Takes Center Stage journal June 2009
Kinetics of binding, endocytosis, and recycling of EGF receptor mutants journal April 1992
Cell-free expression of functional receptor tyrosine kinases journal August 2015
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation journal July 2003
Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer journal May 2006
The Crystal Structure of a Truncated ErbB2 Ectodomain Reveals an Active Conformation, Poised to Interact with Other ErbB Receptors journal February 2003
Functional and Structural Stability of the Epidermal Growth Factor Receptor in Detergent Micelles and Phospholipid Nanodiscs journal September 2008
Ligand-induced ErbB receptor dimerization journal February 2009
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex journal April 2004
Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor journal February 2010
Targeting HER proteins in cancer therapy and the role of the non-target HER3 journal July 2007
ERBB3/HER3 and ERBB2/HER2 Duet in Mammary Development and Breast Cancer journal May 2008
Loss of Nrdp1 Enhances ErbB2/ErbB3-Dependent Breast Tumor Cell Growth journal November 2006
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab journal February 2003
Comparison of Elisa-Based Tyrosine Kinase Assays for Screening EGFR Inhibitors journal January 2005
Trastuzumab and Antiestrogen Therapy: Focus on Mechanisms of Action and Resistance journal January 2006
Effect of Membrane Fluidity on Tyrosine Kinase Activity of Reconstituted Epidermal Growth Factor Receptor journal March 2001
Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer journal February 2010
Improved yields of the extracellular domain of the epidermal growth factor receptor produced using the baculovirus expression system by medium replacement following infection journal December 1995
Regulation of human EGF receptor by lipids journal May 2011
The Cell-Free Integration of a Polytopic Mitochondrial Membrane Protein into Liposomes Occurs Cotranslationally and in a Lipid-Dependent Manner journal September 2012
Untangling the ErbB signalling network journal February 2001
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene journal January 1987